Geksoral aerosol for topical use 0.2% 40ml №1

Name:
Hexoral
Description:
Transparent colorless liquid with menthol smell. The main active ingredient Hexetidine – 0.200 g. Release form Aerosol for topical use 0.2%. Special instructionsThere are no special instructions. Children can use the drug from an age when there is no danger of uncontrolled swallowing or when they do not resist a foreign object (spray nozzle) in the mouth when using an aerosol and are able to hold their breath when injecting the drug. The ethanol content in the preparation is 5.15%. One dose of the drug contains 20.3 mg of ethanol (in terms of absolute alcohol). The contents of the aerosol can are under pressure. Do not open, pierce or incinerate, even if the container is empty. If the medicinal product has become unusable or the expiration date has expired, do not pour it into wastewater and do not throw it out into the street! Place the medicine in a bag and put it in a trash can. These measures will help protect the environment! Pharmacodynamics The antimicrobial effect of the drug “Geksoral®” is associated with the suppression of oxidative reactions of bacterial metabolism (thiamine antagonist). The drug has a wide spectrum of antibacterial and antifungal activity, in particular against gram-positive bacteria and fungi of the genus Candida, but the drug “Geksoral®” may also have an effect in the treatment of infections caused, for example, by Pseudomonas aeruginosa or Proteus spp. At a concentration of 100 mg / ml, the drug suppresses most strains of bacteria. The development of resistance was not observed. Hexetidine has a weak anesthetic effect on the mucous membrane. The drug has an antiviral effect against influenza A viruses, respiratory syncytial virus (RS-virus), herpes simplex virus type 1, affecting the respiratory tract. Pharmacokinetics Hexetidine adheres very well to the mucous membrane and is practically not absorbed. After a single application of the active substance, its traces are found on the gum mucosa within 65 hours. Active concentrations remain in plaque for 10-14 hours after application. Indications for use As a symptomatic remedy. Symptomatic treatment for inflammatory and infectious diseases of the oral cavity and larynx. – tonsillitis, tonsillitis (including Plaut-Vincent’s tonsillitis, tonsillitis of the lateral ridges), pharyngitis, gingivitis, stomatitis, glossitis, periodontal disease. – fungal diseases. Prevention of infectious complications before and after surgical interventions on the oral cavity and larynx and in injuries, including prevention of infection of the alveoli after tooth extraction. Oral hygiene, including to eliminate bad breath. Method of administration and doses Locally: Children from 3 to 6 years of age: the use of the drug is possible after consultation with a healthcare professional. Adults and children over 6 years of age: treat the affected areas while holding the breath, 1 injection for 1-2 seconds, 2 times a day. Hexetidine adheres to the mucous membrane and thus gives a lasting effect. In this regard, the drug should be used after meals. Use during pregnancy and lactation There is no information about any undesirable effects of the drug “Geksoral®” during pregnancy and during breastfeeding. However, before prescribing Hexoral® to pregnant or lactating women, the physician should carefully weigh the benefits and risks of treatment, given the lack of sufficient data on the penetration of the drug through the placenta and into breast milk. Interaction with other drugs No data available. Contraindications Hypersensitivity to any of the components of the drug. Erosive-desquamous lesions of the oral mucosa. Children’s age up to 3 years. Composition 100 ml of the drug contains: Active ingredient – hexetidine – 0.200 g; Excipients: Polysorbate 80 – 1.400 g, citric acid monohydrate – 0.070 g, sodium saccharinate – 0.040 g, levomenthol – 0.070 g, eucalyptus rod leaves oil – 0.0011 g, sodium calcium edetate – 0.100 g, ethanol 96% – 4.333 g , sodium hydroxide – qs up to pH 5.5 ± 0.2, purified water – qs up to 100 ml, nitrogen – qs up to 5 bar. Overdose It is unlikely that hexetidine can have a toxic effect when used according to the instructions for use of the medicinal product. Swallowing large amounts of a preparation containing ethanol may lead to signs/symptoms of alcohol intoxication. In any case of overdose, consult your doctor immediately. Treatment is symptomatic, as in alcohol intoxication. Gastric lavage is necessary within 2 hours after swallowing an excess dose. Adverse reactions identified during post-registration use of the medicinal product were classified as follows: very common (≥1/10), frequent (≥1/100, <1/10), infrequent (≥1/1000, <1/100 ), rare (≥1/10000, <1/1000), very rare (<1/10000), frequency unknown (frequency of occurrence cannot be estimated from the available data). Immune system disorders. Very rarely: hypersensitivity reactions (including urticaria), angioedema. Nervous system disorders. Very rare: ageusia, dysgeusia. Respiratory, thoracic and mediastinal disorders. Very rarely: cough, shortness of breath due to the appearance of a hypersensitivity reaction. Gastrointestinal disorders. Very rarely: dry mouth, dysphagia, nausea, salivary gland enlargement, vomiting. General disorders and disorders at the injection site. Very rarely: reactions at the site of application (including irritation of the mucous membrane of the oral cavity and pharynx, burning sensation, paresthesia of the oral cavity, discoloration of the tongue, discoloration of the teeth, inflammation, blistering and ulceration). If any side effects indicated in the instructions are aggravated or you notice other side effects, it is recommended to consult a doctor. Storage conditionsStore at a temperature not exceeding 25 °C. Keep out of the reach of children. Buy Hexoral topical aerosol 0.2% 40ml №1 Price for Hexoral topical aerosol 0.2% 40ml №1